Mediation by nitric oxide of the carbachol-induced corticosterone secretion in rats

Journal of Physiology and Pharmacology

Volumn 48, Issue 2, 1997, Pages 277-284

  Bugajski, J ^a,b   Borycz, J ^a   Gadek Michalska A ^a   Glod R ^a   Bugajski, A J ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Central cholinergic stimulation; Corticosterone; Nitric oxide; Nitric oxide synthase antagonists

Indexed keywords

CARBACHOL; CORTICOSTERONE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADRENAL CORTEX; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; CORTICOSTERONE RELEASE; DOSE RESPONSE; ENZYME ANALYSIS; ENZYME INHIBITION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NEUROMODULATION; NONHUMAN; RAT; RECEPTOR UPREGULATION;

ANIMALS; CARBACHOL; CORTICOSTERONE; ENZYME INHIBITORS; INJECTIONS, INTRAVENTRICULAR; MALE; MUSCARINIC AGONISTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, WISTAR;

EID: 0030874381     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Berdeaux A. Nitric oxide: an ubiquitous messenger. Fundam Clin Pharmacol 1993; 7: 401-411.
2. Dawson VL, Dawson TM. Nitric oxide actions in neurochemistry. Neurochem Int 1996; 29; 97-110.
3. Szabo C. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull 1996; 41: 131-141.
4. Prast H, Philippu A. Nitric oxide releases acetylcholine in the basal forebrain. Eur J Pharm 1992; 216: 139-140.
5. Lonart G, Wang J, Johnson KM. Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharm 1992; 220: 271-272.
6. Anderson CR, Mcallen RM, Edwards SL. Nitric oxide synthase and chemical coding in cat sympathetic postganglionic neurons. Neuroscience 1995; 68: 255-264.
7. Leonard TO, Lydic R. Nitric oxide synthase inhibition decreases pontine acetylcholine release. Neuroreport 1995; 6: 1525-1529.
8. Leonard CS, Rao S, Sanchez RM. Patterns of neuromodulation and the nitric oxide signalling pathway in mesopontine cholincrgic neurons. The Neurosciences 1995; 7: 319-328.
9. Calza L, Giardino L, Ceccatelli S. NOS mRNA in the paraventricular nucleus of young and old rats after immobilization stress. Neuroendocrinology 1993; 4: 627-630.
10. Vincent SR, Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain Neuroscience 1992; 46: 755-784.
11. Summy-Long JY, Bui V, Mantz S, Koehler E, Weisz J, Kadekaro M. Central inhibition of nitric oxide synthase preferentially release of oxitocin during dehydration. Neurosci Lett 1993; 152: 190-193.
12. Kato M. Involvement of nitric oxide in growth hormone (GH)-releasing hormone-induced GH secretion in rat pituitary cells. Endocrinology 1992; 131: 2133-2138.
13. 2 in basal and interleukin-1-β-induced PRL release in vitro. Life Sci 1995; 56: PL. 277-283.
14. Costa A, Trainer P., Besser M., Grosman A. Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro. Brain Res 1993; 605: 187-192.
15. Raber J, Koob GF, Bloom FE. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signalling; comparison with the hypothalamic response. J Pharmacol Exp Ther 1995; 272: 815-824.
16. Karanth S, Lyson K, McCann SM. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci 1993; 90: 3383-3387.
17. Sandi C, Guaza C. Evidence for a role of nitric oxide in the corticotropin-releasing factor release induced by interleukin-1β. Eur J Pharmacol 1995; 274: 17-23.
18. Brunetti L, Prezosi P., Ragazzoni E, Vacca M. Involvement of nitric oxide in basal and interleukin-1β-induced CRH and ACTH release in vitro. Life Sci 1993; 53: PL219-222.
19. Bugajski J, Ga̧dek-Michalska A, Borycz J, Bugajski AJ, Głód R. Histaminergic components in carbachol-induced pituitary-adrenocortical activity. J Physiol Pharmacol 1994; 45: 419-428.
20. G-nitro-L-arginine and comparisons to alcohol. Life Sci 1991; 50: PL35-40.
21. Salter M, Duffy C, Hazelwood R. Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results Neuropharmacology 1995; 34: 327-334.
22. Salter M., Duffy C, Garthwaite J, Atrijbos PJLM. Substantial regional and hemispheric differences in brain nitric oxide synthase (NOS) inhibition following intracerebroventricular administration of Nω-nitro-L-arginine (L-NA) and its methyl ester (L-NAME). Neuropharmacology 1995; 34: 639-649.